{
  "id" : "myeloma_plasma_cell_disorder",
  "algorithm" : "tnm",
  "version" : "1.9",
  "name" : "Myeloma Plasma Cell Disorder",
  "title" : "Plasma Cell Disorders including Myeloma",
  "notes" : "9731 Plasmacytoma, NOS (except C441, C690, C695-C696)\n9732 Multiple myeloma (except C441, C690, C695-C696)\n9734 Plasmacytoma, extramedullary (except C441, C690, C695-C696)\n\n**Note:** TNM is not defined for this schema. If directly assigning Summary Stage 2000 (SS2000), use the *Hematopoietic, Reticuloendothelial, Immunoproliferative, and Myeloproliferative Neoplasms* chapter on page 286 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=286).",
  "schema_selection_table" : "schema_selection_myeloma_plasma_cell_disorder",
  "inputs" : [ {
    "key" : "year_dx",
    "name" : "Year of Diagnosis",
    "naaccr_item" : 390,
    "naaccr_xml_id" : "dateOfDiagnosis",
    "table" : "year_dx_validation",
    "used_for_staging" : false
  }, {
    "key" : "site",
    "name" : "Primary Site",
    "naaccr_item" : 400,
    "naaccr_xml_id" : "primarySite",
    "table" : "primary_site",
    "used_for_staging" : true
  }, {
    "key" : "hist",
    "name" : "Histology",
    "naaccr_item" : 522,
    "naaccr_xml_id" : "histologicTypeIcdO3",
    "table" : "histology",
    "used_for_staging" : true
  }, {
    "key" : "ssf2",
    "name" : "Durie-Salmon Staging System",
    "naaccr_item" : 2890,
    "naaccr_xml_id" : "csSiteSpecificFactor2",
    "default" : "987",
    "table" : "ssf2_kbx",
    "used_for_staging" : false,
    "metadata" : [ "COC_REQUIRED", "CCCR_REQUIRED", "SEER_REQUIRED" ]
  }, {
    "key" : "ssf3",
    "name" : "Multiple Myeloma Terminology",
    "naaccr_item" : 2900,
    "naaccr_xml_id" : "csSiteSpecificFactor3",
    "default" : "987",
    "table" : "ssf3_lbb",
    "used_for_staging" : false,
    "metadata" : [ "COC_REQUIRED", "CCCR_REQUIRED", "SEER_REQUIRED" ]
  } ],
  "outputs" : [ {
    "key" : "derived_version",
    "name" : "Derived Version",
    "default" : "{{ctx_alg_version}}"
  }, {
    "key" : "clin_stage_group",
    "name" : "Derived SEER Clin Stage Group",
    "naaccr_item" : 3610,
    "naaccr_xml_id" : "derivedSeerClinStgGrp",
    "default" : "88"
  }, {
    "key" : "path_stage_group",
    "name" : "Derived SEER Path Stage Group",
    "naaccr_item" : 3605,
    "naaccr_xml_id" : "derivedSeerPathStgGrp",
    "default" : "88"
  }, {
    "key" : "combined_stage_group",
    "name" : "Derived SEER Combined Stage Group",
    "naaccr_item" : 3614,
    "naaccr_xml_id" : "derivedSeerCmbStgGrp",
    "default" : "88"
  }, {
    "key" : "combined_t",
    "name" : "Derived SEER Combined T",
    "naaccr_item" : 3616,
    "naaccr_xml_id" : "derivedSeerCombinedT",
    "default" : "88"
  }, {
    "key" : "combined_n",
    "name" : "Derived SEER Combined N",
    "naaccr_item" : 3618,
    "naaccr_xml_id" : "derivedSeerCombinedN",
    "default" : "88"
  }, {
    "key" : "combined_m",
    "name" : "Derived SEER Combined M",
    "naaccr_item" : 3620,
    "naaccr_xml_id" : "derivedSeerCombinedM",
    "default" : "88"
  }, {
    "key" : "source_t",
    "name" : "Derived SEER Combined T Source",
    "naaccr_item" : 3622,
    "naaccr_xml_id" : "derivedSeerCmbTSrc"
  }, {
    "key" : "source_n",
    "name" : "Derived SEER Combined N Source",
    "naaccr_item" : 3624,
    "naaccr_xml_id" : "derivedSeerCmbNSrc"
  }, {
    "key" : "source_m",
    "name" : "Derived SEER Combined M Source",
    "naaccr_item" : 3626,
    "naaccr_xml_id" : "derivedSeerCmbMSrc"
  } ],
  "involved_tables" : [ "primary_site", "ssf2_kbx", "histology", "schema_selection_myeloma_plasma_cell_disorder", "ssf3_lbb", "year_dx_validation" ],
  "on_invalid_input" : "FAIL_WHEN_USED_FOR_STAGING",
  "last_modified" : "2020-06-30T19:47:43.867Z"
}